Background: The optimal duration of prophylaxis against venous thromboembolism after total hip or knee replacement is uncertain. Objective: To determine the efficacy and safety of ex-tended out-of-hospital prophylaxis with low-molecular-weight heparin (ardeparin sodium). Design: Randomized, double-blind, placebo-controlled trial
Objectives: International guidelines recommend thrombosis prophylaxis after total hip arthroplasty (...
Background: Prophylaxis of venous thromboembolism with low-molecular-weight heparins in patients und...
Venous thromboembolism after total hip replacement continues to be a serious problem. We conducted a...
Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controve...
Item does not contain fulltextThe need for prevention of venous thromboembolism (VTE) after total hi...
International audienceOrthopaedic and trauma surgery are classified according 3 groups of venous thr...
We assessed the safety and efficacy of the novel low molecular weight heparinoid Lomoparan (Org 1017...
Venous thromboembolism is a well-established complication of total hip and knee arthroplasty and hip...
ABSTRACT: We compared the efficacy and safety of low-molecular-weight heparin with that of low-dose ...
Vein thromboembolism (VTE) is a potentially severe complication of elective total hip arthroplasty (...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low...
OBJECTIVE--To evaluate the efficacy and safety of two subcutaneous prophylactic regimens for postope...
The optimal regime of antithrombotic prophylaxis for patients undergoing total knee arthroplasty (TK...
The optimal regime of antithrombotic prophylaxis for patients undergoing total knee arthroplasty (TK...
Objectives: International guidelines recommend thrombosis prophylaxis after total hip arthroplasty (...
Background: Prophylaxis of venous thromboembolism with low-molecular-weight heparins in patients und...
Venous thromboembolism after total hip replacement continues to be a serious problem. We conducted a...
Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controve...
Item does not contain fulltextThe need for prevention of venous thromboembolism (VTE) after total hi...
International audienceOrthopaedic and trauma surgery are classified according 3 groups of venous thr...
We assessed the safety and efficacy of the novel low molecular weight heparinoid Lomoparan (Org 1017...
Venous thromboembolism is a well-established complication of total hip and knee arthroplasty and hip...
ABSTRACT: We compared the efficacy and safety of low-molecular-weight heparin with that of low-dose ...
Vein thromboembolism (VTE) is a potentially severe complication of elective total hip arthroplasty (...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low...
OBJECTIVE--To evaluate the efficacy and safety of two subcutaneous prophylactic regimens for postope...
The optimal regime of antithrombotic prophylaxis for patients undergoing total knee arthroplasty (TK...
The optimal regime of antithrombotic prophylaxis for patients undergoing total knee arthroplasty (TK...
Objectives: International guidelines recommend thrombosis prophylaxis after total hip arthroplasty (...
Background: Prophylaxis of venous thromboembolism with low-molecular-weight heparins in patients und...
Venous thromboembolism after total hip replacement continues to be a serious problem. We conducted a...